美女免费一级视频在线观看

    • <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      Gold
      




      Havas Life Rare
      




      Havas Life Rare, formerly H4B Boston, wins gold again this year for its outstanding work as a commercialization and marketing partner for orphan drugs and rare disease markets. In a setting where diagnosis, care pathways, awareness and access are almost always underdeveloped, it strives to use strategic thinking and deep medical knowledge to find the best path forward.
      




      This year, it again proved that with more innovation, including the creation of a rare clinician and patient advisory board to provide insight and inspiration regarding their rare experience to team members and clients. The launch of Havas Media Health (HMH) added expertise in rare disease HCP and patient/caregiver media buying. It has also begun offering advocacy strategy and early commercialization support to clients.
      




      Client testimonials show how closely the agency works to get medicine for rare diseases into providers’ hands. “Havas Life Rare has been an instrumental partner in bringing exceptional strategic and creative thinking to our ultra-rare disease awareness initiatives,” said Jesse Klein, Ipsen’s director of global marketing for rare diseases. “Reaching and educating patients, their loved ones and the HCP community is at the heart of what they do.”
      




      For Rare Disease Day 2023, it sponsored and enabled a full month of rare disease portraits featured on New York City’s Times Square Jumbotron and corresponding social media campaign in collaboration with No Patient Left Behind, a rare disease nonprofit that features the donated portraits of RD patients by notable artists.
      




      The Boston-based agency also reaches into the heart of its people with impressive cultural and religious inclusion, fostering a sense of belonging. Team members again assembled a team for the Red Sox Foundation Run To Home Base event, raising funds for veterans. It also supports Global Genes, producing and selling plantable rare flower-seeded greeting cards.
      




      Silver
      




      DDB Health
      




      With revenue rising 21% to $79 million in 2023, DDB Health distinguished itself with the launch of Fabhalta, a new Novartis product treating a rare blood disease, and Welireg, a Merck drug for advanced renal cell carcinoma. It also strengthened its mentorship efforts and launched Good Works, a program that encourages employees to nominate causes most important to them, spurring a pro bono initiative and more grassroots fundraising and awareness initiatives.
      




      Click here to view 2024 MM+M Award Winners.